SCHEMBL18232134

SCHEMBL18232134

CC(C)Oc1ccc(C(=O)CN2CCN(C)CC2)cc1[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 1/20 0.56
▸ ALDH1A1 P00352 6/20 0.48
▸ KDM4E B2RXH2 5/20 0.48
▸ MAPT P10636 4/20 0.48
▸ LMNA P02545 3/20 0.48
▸ POLB P06746 1/20 0.48
▸ HPGD P15428 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ HTT P42858 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ USP2 O75604 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ PDE5A O76074 1/20 0.41
▸ MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20033128 0.88 PDK1 (0.55) PDK1ALDH1A1KDM4EMAPTLMNA
SCHEMBL18232139 0.87 PDK1 (0.52) PDK1ALDH1A1KDM4EMAPTLMNA
Hydrochloric Acid SCHEMBL31439598 0.87 PDK1 (0.54) PDK1ALDH1A1KDM4EMAPTLMNA
SCHEMBL31439484 0.86 POLB (0.54) PDK1ALDH1A1KDM4EMAPTLMNA
SCHEMBL31439530 0.85 PDK1 (0.52) PDK1ALDH1A1KDM4EMAPTLMNA
SCHEMBL20033129 0.84 PDK1 (0.51) PDK1ALDH1A1KDM4EMAPTLMNA
SCHEMBL20033130 0.81 PDE4B (0.44) ALDH1A1KDM4EMAPTLMNAPOLB
SCHEMBL31439600 0.80 PDK1 (0.58) PDK1ALDH1A1KDM4ELMNAPOLB
SCHEMBL16924922 0.78 PDK1 (0.70) PDK1ALDH1A1LMNAPOLBHTT
SCHEMBL16924930 0.78 PDK1 (0.66) PDK1ALDH1A1LMNAPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9938245-B2 Carbonyl erastin analogs and their use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2018-04-10 — — US disclosed
US-9938245-B2 Carbonyl erastin analogs and their use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2018-04-10 — — US disclosed
US-20160332974-A1 CARBONYL ERASTIN ANALOGS AND THEIR USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2016-11-17 — — US disclosed
US-20160332974-A1 CARBONYL ERASTIN ANALOGS AND THEIR USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2016-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160332974-A1 CARBONYL ERASTIN ANALOGS AND THEIR USE KEAP1, GPX1, GPX4 PDK1 673/4885ALDH1A1 407/4885KDM4E 2326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback